Approximately three hours after admission, his GCS dropped to 7. He was found to have a severe metabolic acidosis (base deficit -23.9 mmol/l); urinary toxicology was negative for salicylates and paracetamol. Based on the history and presentation, we made a provisional diagnosis of ethylene glycol poisoning. He was sedated, intubated, established on mechanical ventilation and transferred to the intensive care unit. On advice from TOXBASE, he was treated with intravenous fluids and given a loading dose of intravenous 10% ethanol followed by a maintenance infusion to achieve a target blood ethanol level of 22 mmol/l. Subsequent blood results showed deteriorating renal function, raised serum osmolarity and high anion gap acidaemia. The clinical diagnosis of ethylene glycol poisoning was confirmed by the detection of one of the toxic metabolites of ethylene glycol, glycolic acid (430 mg/l), in the serum. He developed acute renal failure requiring continuous veno-venous haemofiltration (CVVH).
The following day he suffered a brief asystolic cardiac arrest requiring cardiopulmonary resuscitation for less than a minute. Post-arrest, he was haemodynamically stable and his pupils were reacting. Treatment continued with sedation, ethanol infusion and haemofiltration.
On day three, he developed acute hypertension followed by hypotension and seizures. His pupils were now fixed and dilated. He became apnoeic and lost cranial nerve reflexes (corneal, gag and cough reflexes). A CT scan of brain showed massive cerebral oedema with low attenuation in the basal ganglia, compatible with the clinical suspicion of brainstem herniation.
On discussion with his family it was agreed that, given the severity of his condition, should he suffer a further cardiac arrest, further resuscitation would be inappropriate. His family expressed a wish that he be considered for organ donation and felt that this would be his wish also. To clarify the implications of ethylene glycol poisoning and its treatments for brain stem testing and organ donation, we contacted the National Poisons Information Service (NPIS) and the transplant coordinator. We were advised that in order to fulfil the criteria for brain stem testing, his serum glycolic acid level must be negligible. The transplant co-ordinator advised that he could be considered for internal organ donation.
The ethanol infusion was stopped on the fourth day after serum ethylene glycol levels diminished, and supportive intensive care was continued including CVVH. Throughout the course he remained unresponsive and apnoeic, with absent cranial nerve reflexes. He was started on an organ donor management regime. We continued to monitor serum glycolic acid levels. We also discussed possible withdrawal of treatment with the family in view of futility.
One week after admission, glycolic acid levels were sufficiently low to permit brain stem testing, and brain stem death was then confirmed. His death was reported to the coroner, who requested a post mortem; donation of internal organs was not permitted, although donation of skin and corneas was allowed.
Discussion
The first cases of ethylene glycol toxicity were reported in 1930 when two young men developed terminal respiratory failure and convulsions after ingesting 'Prestone' antifreeze (95% ethylene glycol). 3 Human poisoning has occurred in isolated cases and in epidemics. Multiple cases of ethylene glycol poisoning occurred during the Second World War and also during the 1973 Arab-Israeli conflict. Eighteen soldiers who ingested ethylene glycol as a substitute for ethanol died during World War II. 4 Currently, ethylene glycol poisoning causes hundreds of deaths annually worldwide, with quite variable global incidence.
Comprehensive data is lacking for the United Kingdom. It is estimated that many district hospitals will only see 1-2 cases every 2-3 years. In 2002, an annual report by American Association of Poison Control Centres (AAPCC) recorded 6,077 exposures to ethylene glycol in the United States, resulting in 40 deaths and 254 near-fatalities. 5 The most common sources of ethylene glycol are automotive antifreeze (generally available in a 95% concentration), engine coolant, hydraulic brake fluid and paint. Patients may ingest ethylene glycol as an alternative to alcohol, to inflict self-harm or by accident. Multiple poisonings have been reported after environmental accidents due to contamination of water systems. 6 Establishing the diagnosis of ethylene glycol poisoning can be challenging. The most conclusive diagnostic test is direct measurement of serum or urine ethylene glycol concentration. However, there is a poor correlation between the blood
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concentration of ethylene glycol and the severity of poisoning. 7 Blood levels of metabolites of ethylene glycol, mainly glycolate, guide treatment with the antidote. Other features such as severe metabolic acidosis, raised serum osmolar gap, raised anion gap, hypocalcemia and presence of urine crystals support the diagnosis. In our patient, serum osmolality was 339 msom/kg with an osmolar gap of 39 mmol/l (normal 10 mosm/l) and the anion gap was 33 mmol/l (normal 12 -15 mmol/l). Laboratory results should be interpreted with caution, depending on the time of ingestion of ethylene glycol. In the early stages, acid metabolites may not yet have formed; late presentation may not reveal an increased osmolar gap because the ethylene glycol has already been converted to toxic, but osmotically inactive, products.
It has been reported that glycolate causes large artifactual elevations in plasma L-lactate measurements if tested with two analysers in common use, with the potential for misdiagnosis of lactic acidosis in ethylene glycol poisoning. 8 In our patient initial lactate was measured as > 48 mmol/l.
As this patient was treated in a District General Hospital, samples for ethylene glycol and its metabolites were sent to another hospital laboratory. Not all laboratories can perform assays for ethylene glycol, creating potential delays in diagnosis and treatment. It is important not to delay initiating treatment in the absence of serum levels.
There are three primary goals in treating ethylene glycol poisoning: • correction of the patient's metabolic acidaemia • prevention of metabolism of the compound to its toxic metabolites • removal of ethylene glycol and its toxic metabolites using haemodialysis if necessary.
The recommended antidote for ethylene glycol intoxication is ethanol. 9 It binds to alcohol dehydrogenase preventing the metabolism of ethylene glycol into toxic products. Ease of availability, relatively low cost and clinical effectiveness have all promoted its use in this context despite availability of other alternatives (see below) and drawbacks with its use. 10 The accepted target plasma ethanol concentration is 100 to 125 mg/dl (21.7 to 27.1 mmol/l). 11 Since patients treated with large doses of ethanol become intoxicated, they must be closely monitored. CNS depression, circulatory instability and respiratory depression from ethanol make management of the already poisoned patient more difficult. It is difficult to maintain effective concentrations of ethanol in the blood, especially during haemodialysis which removes ethanol. Because the kinetics of ethanol are unpredictable, blood concentrations must be measured frequently. For all these reasons ethanol is not an ideal antidote. 12 In 1988 fomepizole (4-methylpyrazole) 13 was introduced as an effective competitive inhibitor of alcohol dehydrogenase that appears to have none of the adverse effects of ethanol. 11 There are case reports suggesting fomepizole's efficacy. Phase 1 trials funded by US Food and Drug Administration (FDA) 14, 15 have been reported, proving its safety and providing pharmacokinetic data.
There is at least one prospective study 16 that confirms its safety profile and its effectiveness in preventing renal injury by inhibiting formation of toxic metabolites. Given the practical problems related to ethanol administration and its side effects, fomepizole appears to be the preferred treatment. However, the cost of treatment with fomepizole (about $4,000) per case still makes ethanol the preferred option if resources are limited. 12 Nevertheless, the use of fomepizole may be cost effective, in that there is no need to measure blood ethanol levels and that patients treated may need haemodialysis less often, and there may be reduced length of stay in intensive care unit.
In the UK the treatment for poisoning is assisted by guidelines from TOXBASE, an online database maintained by National Poisons Information Service (NPIS). 17 Although NPIS guidelines 18 recommend the use of fomepizole as an alternative to ethanol to treat ethylene glycol, there are practical barriers to its use. Fomepizole is not usually available from hospital pharmacies and has to be obtained from NPIS regional centres. This could result in an undesirable delay in treatment.
Because of the low incidence of poisoning, it is hard to obtain high quality evidence for best treatment. Although ethanol is the traditional antidote for ethylene glycol poisoning, it has not been studied prospectively nor approved by governing organisations such as the FDA. 10 The FDA recently approved the use of fomepizole as an effective antidote for ethylene glycol intoxication. There are no clinical studies that directly compare the efficacy of fomepizole with that of ethanol. 10, 19 Haemodialysis is effective to remove both ethylene glycol and its toxic metabolites from the circulation and to correct metabolic acidosis. It has been used in severe ethylene glycol poisoning for many years and prospectively studied to assess clearance rates and efficacy. 20 In a case series continuous veno-venous haemodiafiltration was used with significant clearance of ethylene glycol, 2 but there is insufficient data available regarding the use of haemodiafiltration or haemofiltration in this context.
Organ Donation
In a national survey conducted in UK it was shown that most transplantation physicians, surgeons and intensive care unit directors would consider those who die following acute drug intoxication and poisoning as potential organ donors. 21 Although the number of reports is small, the literature shows in general that the transplanted organs from poisoned patients have good long-term survival. There are number of published cases of successful kidney, liver and heart transplantation, and one report of successful lung transplantation from methanol-poisoned patients. The largest series involved a total of 38 transplanted organs (29 kidneys, 4 hearts and 5 livers) from 16 donors who died from methanol poisoning. 22 At 1 year follow up, the 3 heart and 3 liver recipients, and 92.6% of the kidney recipients had normal graft function. These figures are comparable to the short-term and long-term outcomes from non-poisoned donors in the same centres over this time. 22 In another series, 13 kidneys, 3 livers, 1 heart and 1 bilateral lung were successfully transplanted from 7 methanol-poisoned donors. 23 There is no published data available relating to such transplants following ethylene glycol poisoning. However, this evidence suggests that patients who have died of poisoning could be potential organ donors and who are at present probably not often referred for transplantation.
This case highlights an unusual clinical situation that presented difficult decisions at every stage. There were practical problems associated with diagnosis and treatment, dilemmas about the use of safe and effective antidotes and interventions, and difficult ethical issues surrounding organ donation. The major ethical dilemma was the appropriateness of continuing life support to ensure organ viability for donation when no longer beneficial to the patient's outcome. While this may be commonly done for short periods, in the poisoned patient it may take several days for toxic metabolites to reach acceptable levels before brain stem testing. Is such a delay acceptable? Is it ethical to prolong life artificially when there is no benefit to the patient? And if so, how long is acceptable? These questions do not have easy answers.
